LungLife AI, Inc. (the “Company” or “LungLife”) Final Pricing Determination Medicare Grants Pricing for LungLife’s LungLB® Early Lung Cancer Diagnostic LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, announces that the Centers for Medicare & Medicaid Services (“CMS”) has granted a price at $2,030 per test for the LungLB® early […]